Home / Companies / Towa (Pensa)
Company family · HQ JP
Towa (Pensa): medicine shortages
As of 2 Nov 2026, 201 Towa (Pensa) products have a reported shortage across 4 countries, covering 102 medicines.
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
Latest changes
All changesNo changes recorded yet. Changes are tracked from our daily snapshots.
Open shortages over time
Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
Download CSV| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Candesartan | 8 | 31 Oct 2024 | Manufacturing problem | 10/16 | |
| Rosuvastatin | 7 | 7 Aug 2026 | Other | 12/16 | |
| Quetiapine | 6 | 6 Feb 2025 | Not stated | 12/16 | |
| Olmesartan Medoxomil | 5 | 30 May 2025 | Manufacturing problem | 5/16 | |
| Pregabalin | 5 | 1 Jun 2026 | Manufacturing problem | 11/16 | |
| Atorvastatin and Amlodipine | 4 | 18 Jun 2026 | Manufacturing problem | 2/16 | |
| Montelukast | 4 | 1 Oct 2025 | Increased demand | 13/16 | |
| Risperidone | 4 | 6 Aug 2026 | Manufacturing problem | 13/16 | |
| Aciclovir | 3 | 1 Aug 2026 | Manufacturing problem | 6/16 | |
| Alprazolam | 3 | 1 Jul 2026 | Manufacturing problem | 6/16 | |
| Eletriptan | 3 | 1 Jan 2026 | Not stated | 7/16 | |
| Levofloxacin | 3 | 6 Aug 2026 | Manufacturing problem | 2/16 | |
| Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide | 3 | 10 May 2026 | Not stated | 3/16 | |
| Pramipexole | 3 | 1 Oct 2025 | Manufacturing problem | 6/16 | |
| Tadalafil | 3 | 1 Aug 2026 | Manufacturing problem | 10/16 | |
| Valsartan | 3 | 1 Jul 2026 | Manufacturing problem | 7/16 | |
| Alendronic Acid | 2 | 3 Aug 2026 | Not stated | 7/16 | |
| Amlodipine | 2 | 11 Dec 2025 | Manufacturing problem | 8/16 | |
| Amoxicillin and Beta-Lactamase Inhibitor | 2 | 1 Jul 2026 | Increased demand | 7/16 | |
| Atenolol | 2 | 22 Oct 2026 | Manufacturing problem | 6/16 | |
| Atorvastatin | 2 | 1 Nov 2026 | Manufacturing problem | 11/16 | |
| Calcium Levofolinate | 2 | 29 Oct 2026 | Increased demand | 2/16 | |
| Escitalopram | 2 | 13 Apr 2026 | Manufacturing problem | 10/16 | |
| Ezetimibe | 2 | 22 Oct 2026 | Increased demand | 9/16 | |
| Famotidine | 2 | 29 Oct 2026 | Increased demand | 4/16 | |
| Fexofenadine | 2 | 7 Aug 2026 | Other | 3/16 | |
| Gabapentin | 2 | 1 Jul 2026 | Increased demand | 9/16 | |
| Memantine | 2 | 6 Aug 2026 | Manufacturing problem | 8/16 | |
| Mesalazine | 2 | 9 Jul 2026 | Manufacturing problem | 11/16 | |
| Metoclopramide | 2 | 1 Oct 2025 | Not stated | 6/16 | |
| Moxifloxacin | 2 | 21 Jun 2026 | Not stated | 8/16 | |
| Sertraline | 2 | 2 Apr 2026 | Increased demand | 11/16 | |
| Tamsulosin | 2 | 3 Sep 2026 | Increased demand | 6/16 | |
| Telmisartan and Amlodipine | 2 | 30 Oct 2026 | Manufacturing problem | 3/16 | |
| Vardenafil | 2 | 6 Aug 2026 | Manufacturing problem | 6/16 | |
| Voriconazole | 2 | 7 Aug 2026 | Increased demand | 6/16 | |
| Aciclovir | 1 | 22 Oct 2026 | Increased demand | 2/16 | |
| Atorvastatin and Ezetimibe | 1 | 1 Nov 2026 | Manufacturing problem | 6/16 | |
| Azithromycin | 1 | 22 Oct 2026 | Increased demand | 1/16 | |
| Benidipine | 1 | 22 Oct 2026 | Manufacturing problem | 1/16 | |
| Beraprost | 1 | 22 Oct 2026 | Increased demand | 1/16 | |
| Bisoprolol | 1 | 1 Jul 2026 | Manufacturing problem | 6/16 | |
| Bromazepam | 1 | 16 Jun 2026 | Not stated | 4/16 | |
| Candesartan and Amlodipine | 1 | 2 Apr 2026 | Manufacturing problem | 3/16 | |
| Cefalexin | 1 | 23 May 2024 | Quality problem or recall | 3/16 | |
| Desloratadine | 1 | 1 Sep 2026 | Manufacturing problem | 7/16 | |
| Dexketoprofen | 1 | 1 Jul 2026 | Manufacturing problem | 2/16 | |
| Dienogest | 1 | 2 Apr 2026 | Manufacturing problem | 2/16 | |
| Domperidone | 1 | 6 Jul 2023 | Not stated | 5/16 | |
| Doxazosin | 1 | 1 Nov 2026 | Manufacturing problem | 5/16 | |
| Dutasteride | 1 | 1 Jan 2027 | Manufacturing problem | 4/16 | |
| Entecavir | 1 | 2 Apr 2026 | Manufacturing problem | 8/16 | |
| Eperisone | 1 | 10 Dec 2025 | Increased demand | 1/16 | |
| Etoricoxib | 1 | 20 Dec 2026 | Manufacturing problem | 7/16 | |
| Famciclovir | 1 | 19 May 2026 | Not stated | 2/16 | |
| Famciclovir | 1 | 29 Oct 2026 | Increased demand | 1/16 | |
| Fenofibrate | 1 | 30 Jun 2026 | Not stated | 2/16 | |
| Finasteride | 1 | 1 Oct 2026 | Manufacturing problem | 2/16 | |
| Finasteride | 1 | 1 Oct 2025 | Manufacturing problem | 8/16 | |
| Fosfomycin | 1 | 6 Oct 2026 | Not stated | 4/16 | |
| Galantamine | 1 | 6 Aug 2026 | Manufacturing problem | 7/16 | |
| Ibuprofen | 1 | 1 Nov 2026 | Increased demand | 8/16 | |
| Lamotrigine | 1 | 6 Aug 2026 | Manufacturing problem | 9/16 | |
| Lansoprazole | 1 | 22 Oct 2026 | Increased demand | 8/16 | |
| Letrozole | 1 | 21 Jul 2026 | Increased demand | 6/16 | |
| Levetiracetam | 1 | 1 Dec 2026 | Manufacturing problem | 9/16 | |
| Loratadine | 1 | 22 Oct 2026 | Manufacturing problem | 5/16 | |
| Lorazepam | 1 | 1 Dec 2026 | Manufacturing problem | 5/16 | |
| Losartan | 1 | 1 Aug 2026 | Manufacturing problem | 6/16 | |
| Metamizole Sodium | 1 | 25 Jun 2026 | Not stated | 2/16 | |
| Methotrexate | 1 | 22 Oct 2026 | Manufacturing problem | 6/16 | |
| Miglitol | 1 | 7 Jan 2026 | Manufacturing problem | 1/16 | |
| Mirtazapine | 1 | 22 Oct 2026 | Manufacturing problem | 10/16 | |
| Nebivolol | 1 | 1 Sep 2026 | Manufacturing problem | 4/16 | |
| Nifedipine | 1 | 3 Apr 2023 | Quality problem or recall | 6/16 | |
| Norethisterone and Ethinylestradiol | 1 | 1 Oct 2025 | Manufacturing problem | 2/16 | |
| Norfloxacin | 1 | 25 Jul 2026 | Not stated | 3/16 | |
| Olanzapine | 1 | 14 Dec 2026 | Manufacturing problem | 13/16 | |
| Olopatadine | 1 | 30 May 2025 | Manufacturing problem | 2/16 | |
| Paracetamol | 1 | 15 Dec 2026 | Manufacturing problem | 10/16 | |
| Paroxetine | 1 | 1 Nov 2026 | Manufacturing problem | 8/16 | |
| Prednisone | 1 | 1 Nov 2026 | Manufacturing problem | 1/16 | |
| Rabeprazole | 1 | 16 Apr 2026 | Increased demand | 5/16 | |
| Ramipril and Diuretics | 1 | 1 Dec 2026 | Manufacturing problem | 4/16 | |
| Repaglinide | 1 | 1 Aug 2026 | Manufacturing problem | 5/16 | |
| Ropinirole | 1 | 22 Oct 2026 | Manufacturing problem | 8/16 | |
| Roxithromycin | 1 | 22 Oct 2026 | Increased demand | 3/16 | |
| Simvastatin | 1 | 1 Nov 2026 | Manufacturing problem | 9/16 | |
| Sitagliptin | 1 | 1 Oct 2026 | Manufacturing problem | 8/16 | |
| Tamsulosin and Solifenacin | 1 | 29 Sep 2026 | Not stated | 5/16 | |
| Teicoplanin | 1 | 22 Oct 2026 | Increased demand | 5/16 | |
| Terbinafine | 1 | 16 Jul 2026 | Increased demand | 5/16 | |
| Theophylline | 1 | 8 Apr 2025 | Manufacturing problem | 3/16 | |
| Timolol, Combinations | 1 | 16 Nov 2026 | Manufacturing problem | 9/16 | |
| Tocopherol (Vit E) | 1 | 1 Oct 2025 | Manufacturing problem | 1/16 | |
| Tramadol and Paracetamol | 1 | 22 Oct 2026 | Manufacturing problem | 5/16 | |
| Trimebutine | 1 | 3 Apr 2023 | Increased demand | 2/16 | |
| Valaciclovir | 1 | 29 Oct 2026 | Increased demand | 10/16 | |
| Valsartan and Diuretics | 1 | 1 Dec 2026 | Increased demand | 7/16 | |
| Vancomycin | 1 | 6 Aug 2026 | Manufacturing problem | 5/16 | |
| Zolpidem | 1 | 1 Oct 2025 | Manufacturing problem | 6/16 | |
| glyceryl trinitrate | 1 | 15 Oct 2026 | Quality problem or recall | 1/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.